A common symptom of COVID-19 is a partial or complete loss of smell. The virus infects sustentacular cells in the olfactory epithelium and is thought to impair thereby the activity of the sensory neurons in this epithelium.
Dec 8, 2022
0
104
SARS-CoV-2 causes a broad range of clinical symptoms, including potentially fatal acute respiratory distress syndrome (ARDS). A study by Kirsty Short at University of Queensland, Queensland, Australia, and colleagues, published ...
Aug 1, 2022
0
51
Perioperative neurocognitive disorder (PND) is one of the most common postoperative complications in older adults and is associated with adverse postoperative outcomes. However, the causes, underlying mechanisms and the interventions ...
Jul 20, 2022
0
19
Some studies have suggested electronic cigarette (EC) use may be a healthier alternative to cigarette smoking. A University of California, Riverside, study shows this is far from the case.
Jul 12, 2022
0
35
New research at National Jewish Health shows that allergic asthma fundamentally transforms the human airway, reducing cells' ability to remove pollutants and fight infections. Allergic asthma, the most common form of the ...
Sep 3, 2020
0
160
Doctors have reported that partial or total loss of the sense of smell is often an early symptom of infection with SARS-CoV-2, the virus that causes COVID-19. Now, researchers reporting in ACS Chemical Neuroscience have shown ...
May 11, 2020
0
46
New research from Griffith University has shown that damage to the lining inside the nose increases the risk of bacteria sneaking into the brain via nerves, potentially causing long-term health issues.
Mar 17, 2020
0
230
Dogs, known for their extraordinarily keen senses of smell, can be trained to use their sensitive sniffers to find drugs, bombs, bed bugs, missing hikers and even cancer. Among dogs and other animals that rely on smell, at ...
Aug 10, 2018
0
163
A new nasal test may allow patients suspected of having lung cancer to undergo a simple swab of their nose to determine if they have the disease.
Feb 27, 2017
0
2
Tefina, the first testosterone based intranasal gel, has been in part developed by the ULg's Galenic Pharmacy Laboratory. It is currently at the stage of testing before being marketed by the Canadian company, Trimel Pharmaceuticals.
Nov 19, 2012
1
0
